학술논문
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study
Document Type
Article
Author
Source
In: Diabetes, Obesity and Metabolism . (Diabetes, Obesity and Metabolism, July 2021, 23(7):1505-1517)
Subject
Language
English
ISSN
14631326
14628902
14628902